{
    "Trade/Device Name(s)": [
        "BD GeneOhm\u2122 Cdiff Assay"
    ],
    "Submitter Information": "BD Diagnostics (GeneOhm Sciences Canada, Inc.)",
    "510(k) Number": "K081920",
    "Predicate Device Reference 510(k) Number(s)": [
        "K935296",
        "K923463"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LLH"
    ],
    "Summary Letter Date": "July 2, 2008",
    "Summary Letter Received Date": "July 3, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.2660"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin B gene (tcdB)"
    ],
    "Specimen Type(s)": [
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [
        "Sterile dry swab"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid SmartCycler\u00ae"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Polymerase chain reaction",
        "Fluorogenic target-specific hybridization probes"
    ],
    "Methodologies": [
        "Genotypic detection",
        "Molecular beacon hybridization"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD GeneOhm\u2122 Cdiff Assay using real-time PCR and molecular beacon technology for detection of C. difficile toxin B gene in stool specimens",
    "Indications for Use Summary": "Rapid in vitro diagnostic assay for direct, qualitative detection of C. difficile toxin B gene (tcdB) in human liquid or soft stool specimens from patients suspected of having Clostridium difficile-associated disease (CDAD), aiding diagnosis",
    "fda_folder": "Microbiology"
}